- Upper Providence, Pennsylvania USA
Our largest US-based operation, the Upper Providence R&D hub features 8 smart labs and more than 3,000 GSK people discovering and developing new medicines which will change lives.
- Stevenage, United Kingdom
Innovative life sciences R&D hub in Stevenage with more than 2,500 GSK people discovering and developing differentiated, high-quality and important medicines for patients.
- Rixensart and Wavre, Belgium
Discovering and developing vaccines since 1958. Today, about 2.000 people are focused on the discovery of therapeutic vaccines for chronic diseases and adjuvant technology and the development of innovative vaccines, including our shingles vaccine.
- Siena, Italy
With a 100-year history, more than 900 GSK people support our Siena R&D hub with a focus on bacterial vaccines and monoclonal antibodies, including those against meningococcal disease.
Our leading R&D centres in UK, US, Belgium and Italy are pivotal in helping to get ahead of disease around the world.